Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02011412
NCT02011412CompletedNot Applicable

The Intermountain Risk Score's Association With Mortality Prediction in Trauma Patients

Intermountain Health Care, Inc.1 site in 1 country400 target enrollmentStarted: October 2013Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
400
Locations
1
Primary Endpoint
all cause mortality
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The investigators hypothesize that a risk score composed of age, sex, and the components of commonly ordered laboratory panels will be predictive of mortality in trauma patients, and will help improve clinicians' ability to make more accurate mortality predictions at the time of admission.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patient presents to Intermountain Medical Center as a Level I or Level II trauma activation.

Exclusion Criteria

  • •Patients who are not admitted to the hospital
  • •Patients who expire in the Emergency Department
  • •Patients who are discharged to home from the Emergency Department
  • •Patients who do not have a complete blood count and basic metabolic profile drawn in the Emergency Department as part of routine clinical care.
  • •Patients who enter the hospital as "trauma consults." These patients have traumatic injuries, and are often admitted to the trauma service, but the severity of their trauma is not thought to warrant trauma team activation.

Outcomes

Primary Outcomes

all cause mortality

Time Frame: 1 year

measure the ability of the Intermountain Risk Score to predict all cause mortality at one year after the traumatic event

Secondary Outcomes

  • Experienced Clinicians' mortality prediction(1 year)
  • experienced clinicians mortality prediction(30 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sarah Majercik

Sarah Majercik MD, MBA, FACS, Division of Trauma and Surgical Critical Care

Intermountain Health Care, Inc.

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 4
Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B VaccHepatitis BHepatitis A
NCT00289731GlaxoSmithKline596
Completed
Not Applicable
THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm MonitoringPatients With Symptoms of Cardiac Arrhythmia at Risk for Atrial Fibrillation
NCT01970969Scripps Translational Science Institute928
Recruiting
Unknown
Prediction of Patellofemoral Pain Syndrome in Runners
CTRI/2024/04/065410Manav Rachna International Institute of Research and Studies
Not yet recruiting
Unknown
A study of risk factors responsible for fever after retrograde intrarenal surgery(RIRS)
CTRI/2023/11/059529nil
Recruiting
Unknown
Study on risk factors, risk predictors, and trigger factors for the development of acute coronary syndrome in newly diagnosed cardiovascular disease patients between 18-45 years of age.
CTRI/2024/04/065315Bhaktivedanta Hospital and Research Institute